CEASE-AF

• Research type

  Research Study

• Full title

  Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation.\n\nA randomized international multicenter trial comparing interventional treatment\nstrategies in symptomatic patients with drug refractory atrial fibrillation

• IRAS ID

  193601

• Contact name

  Steven Hunter

• Contact email

  steven.hunter@sth.nhs.uk

• Sponsor organisation

  AtriCure Europe B.V.

• Clinicaltrials.gov Identifier

  NCT02695277

• Duration of Study in the UK

  4 years, 6 months, 1 days

• Research summary

  This study plans to investigate if the hybrid approach, combining a minimally invasive surgical ablation technique and normal catheter ablation techniques in a two-staged fashion, provides freedom from the symptoms of Atrial Fibrillation through 36 months compared with repeated catheter ablation (standard of care) in patients with persistent AF and enlarged left atrium or long-standing persistent AF.

• REC name

  East Midlands - Derby Research Ethics Committee

• REC reference

  16/EM/0043

• Date of REC Opinion

  1 Mar 2016

• REC opinion

  Further Information Favourable Opinion